PlainRecalls
FDA Drug Moderate Class II Terminated

ULTRA-TEST (CYP 80%/PROP 20%) Injectable, 250 mg/mL 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL

Reported: January 11, 2017 Initiated: September 21, 2016 #D-0328-2017

Product Description

ULTRA-TEST (CYP 80%/PROP 20%) Injectable, 250 mg/mL 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL

Reason for Recall

Lack of Assurance of Sterility

Details

Units Affected
157 vials
Distribution
Nationwide
Location
Ocala, FL

Frequently Asked Questions

What product was recalled?
ULTRA-TEST (CYP 80%/PROP 20%) Injectable, 250 mg/mL 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL. Recalled by Wells Pharmacy Network LLC. Units affected: 157 vials.
Why was this product recalled?
Lack of Assurance of Sterility
Which agency issued this recall?
This recall was issued by the FDA Drug on January 11, 2017. Severity: Moderate. Recall number: D-0328-2017.